Issue 15, 2009
HOT TOPICS IN VIRAL HEPATITIS
Management of hepatitis B in 2009
Publ.date: 2009
ISBN: 978-88-6450-030-0
ISSN: 1973-9648
E-ISSN: 2036-0932
DOI: 10.4147/HTV-091500
Abstract
Since this monograph has no abstract, we have provided an extract of the first 100 words of the first article.
Infection with hepatitis B virus (HBV), despite the availability of effective vaccines, remains a major cause of life-threatening liver diseases and occurs as a serologically apparent—that is, hepatitis B surface antigen (HBsAg) positive—chronic infection in at least 370 million people worldwide. Recent World Health Organization (WHO) estimates imply that up to 2 billion people have been exposed to HBV, which further emphasizes the global epidemiological significance of this infection [1]. Assays for the identification of HBV proteins, antibodies directed to antigenic epitopes of these proteins, as well as HBV deoxyribonucleic acid (DNA), have been developed and are utilized […]
Presentation of:
Editor-in-chief Francesco Negro - MD
Over the last 20 years, there have been great strides in the treatment of viral hepatitis. Both the discovery of the hepatitis C and E viruses, with the characterization of their genomes, and the...
READ ALL >